drugset / Trial / NCT04854174

A Food Effect Study of ZN-d5 in Healthy Female Volunteers

NCT04854174

Phase 1 Completed 16 enrolled Zentalis Pharmaceuticals, Inc.
NaSingle-groupOpen-labelOther

Summary

This is a single-center, sequential, open-label, food effect study to determine the comparative bioavailability of ZN-d5 under fasting and fed conditions, following single-dose oral administration of ZN-d5. The study will be comprised of a pre-study screening, followed by administration of a single dose of ZN-d5 under fasted conditions, a washout period, administration of a single dose of ZN-d5 under fed conditions, and a follow-up period.

Timeline

Start
2021-06-13
Primary completion
2021-06-30
Completion
2021-07-05

Drugs

EvaluationDrugModalityDoseRoute
Subject ZN-d5 Unknown 25 mg Oral

Indications

No indication recorded.